Shamgar Ben-Eliyahu
Tel Aviv University · Tel Aviv University, Neuroimmunology Research Unit
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shamgar Ben-Eliyahu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:01 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06839144 · Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer ProgressionTel-Aviv Sourasky Medical Center · recruiting · Ovarian Cancer, Ovarian Cancer Metastatic Recurrent · principal investigator
- N/ANCT00502684 · Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer SurgeryKaplan Medical Center · unknown · Primary Operable Breast Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Inhibiting beta-adrenergic and COX-2 signaling during the perioperative period to reduce ovarian cancer progressionR21CA291683 · NCI · TEL AVIV UNIVERSITY · fiscal years 2024 to 2025 · $137,569 awarded in 2025Grant number is on one of their registry trials
- STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCER01CA172138 · NCI · TEL AVIV UNIVERSITY · fiscal years 2013 to 2017 · $199,019 awarded in 2017Same name and institution; not confirmed by an ID
- Psychoneuroimmunology-Immunotherapy interactionsR01CA125456 · NCI · TEL AVIV UNIVERSITY · fiscal years 2007 to 2011 · $185,986 awarded in 2011Same name and institution; not confirmed by an ID
- MECHANISMS AND PREVENTION OF SURGERY-INDUCED METASTASISR01CA073056 · NCI · TEL AVIV UNIVERSITY · fiscal years 1996 to 2005 · $135,000 awarded in 2005Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:01 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.Clin Cancer Res · 2017240 citationsRCR 7.7
- Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial.Contemp Clin Trials · 2008123 citationsRCR 3.7
- 105 citationsRCR 4.5
- Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.Brain Behav Immun · 201875 citationsRCR 2.6
- Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity.Br J Cancer · 200032 citationsRCR 0.7
- Resilience of the immune system in healthy young students to 30-hour sleep deprivation with psychological stress.Neuroimmunomodulation · 201321 citationsRCR 0.8
- Peri-operative individually tailored psychological intervention in breast cancer patients improves psychological indices and molecular biomarkers of metastasis in excised tumors.Brain Behav Immun · 202414 citationsRCR 2.1